HIGH-GRADE SEROUS OVARIAN CARCINOMA
Clinical trials for HIGH-GRADE SEROUS OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes aim at Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called ATX-295 in about 90 adults with advanced solid tumors, including ovarian and breast cancers that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects, while also …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New drug hopes to supercharge immune cells against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called AZD6750, which is designed to guide the immune system to attack cancer cells. It is for adults with advanced solid tumors like melanoma, lung cancer, or breast cancer that have not responded to other treatments. The study will check …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 12:07 UTC